Stem cell co Pluristem awarded $8.7m EU grant

14:00 EDT 6 Sep 2017 | Globes

The grant from the EU R&D Horizon 2020 program is for the Haifa based company's Phase III study of PLX-PAD cells to support recovery following surgery for femoral neck (hip) fracture.

Original Article: Stem cell co Pluristem awarded $8.7m EU grant


More From BioPortfolio on "Stem cell co Pluristem awarded $8.7m EU grant"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...